Medicine Information

Marketing Authorisation - Medicinal Products


Marketing Authorisation: Medicinal Products The case of R (on the application of Merck Sharp and Dohme Ltd) v Licensing Authority [2005], concerned the application for marketing authorisation for a generic product which was based on Product C (see below).

The claimant had marketing authorisations for three medicinal products used in the treatment of osteoporosis and three generic companies sought marketing authorisation for Product C.

Product A - was authorised by the European Community in 1993;

Product B - was authorised in 2000

Product C - was a generic product based on Product B (a copy of Product B).

When a company applies for marketing authorisation for a product, it is a requirement under the European Parliament and Council Directive (EC) 2001/83 (the "Directive"), to supply a full set of data in order to show the safety and efficacy of the product.

There are instances under the Directive when an applicant can simply rely on data submitted in respect of a previously authorised product. For instance, the applicant could refer to data already submitted in respect of a product with marketing authorisation, where the applicant is seeking authorisation for a product 'essentially similar' to a product holding a marketing authorisation for ten years (as per the United Kingdom and pursuant to art 10(i)(a)(iii) of the Directive).

In seeking marketing authorisation for Product C, the generic companies relied on data submitted in relation to Product A and Product B. However, although Product A and Product B contained the same active ingredient, they were not 'essentially similar' within the meaning of the Directive. This meant that they differed in respect of their posology (the schedule of dosage). The defendant accepted that the generic companies did not have to provide any further data but the claimant argued that such an approach was unlawful and in breach of the Directive. The claimant made a reference to the European Court of Justice ("Court of Justice").

The claimant contended that the issue was as yet unresolved by the rules laid down in previous decisions of the ECJ. In particular, it was argued, that there had been no cases where a difference in posology had been the subject of a decision.

The application was dismissed. The ECJ held that:

The principles laid down by the ECJ in earlier decisions were clearly applicable in this case and there was no uncertainty;

Although it was true that a change in posology had not previously been the subject of a decision, it was for the ECJ to interpret the EC Treaty and the relevant principles by which it was to be interpreted, and for the domestic court to apply those principles to the particular case. No new principles arose in the instant case.

If you require further information contact us.

Email: enquiries@rtcoopers.com

RT COOPERS, 2005. This Briefing Note does not provide a comprehensive or complete statement of the law relating to the issues discussed nor does it constitute legal advice. It is intended only to highlight general issues. Specialist legal advice should always be sought in relation to particular circumstances.

Rosanna Cooper is a partner in RT Coopers Solicitors a full service law firm in London. The firm specialises in patents, trade marks, copyright, designs, technology transfer, biotechnology and pharmaceutical law. The firm has a flexible approach to fees and provides the highest quality legal advice.

Contact us at enquiries@rtcoopers.com. visit our website at http://www.rtcoopers.com


MORE RESOURCES:
This RSS feed URL is deprecated, please update. New URLs can be found in the footers at https://news.google.com/news


Science Daily

Distinct human mutations can alter the effect of medicine
Science Daily
By mining existing data sets they have mapped the extent to which mutations occur within GPCR drug targets in individuals and studied what impact these mutations could have on the therapeutic effect of medicine. "We estimate that an average of 3 ...

and more »


UCSF News Services

2018 Precision Medicine World Conference to Feature UCSF Faculty
UCSF News Services
For the third consecutive year, UC San Francisco is co-sponsoring the Precision Medicine World Conference (PMWC) in January 2018 to share the latest in the rapidly evolving space. Renamed from the Personalized Medicine World Conference, the annual ...



International Atomic Energy Agency

Remarks at Conclusion of International Conference on Radiation Protection in Medicine
International Atomic Energy Agency
I understand that it has been a productive meeting. I thank all of you for taking part and sharing your insights and experience in this very important area. Nuclear and radiation safety is a national responsibility, but the IAEA's 168 Member States ...



Healthcare IT News

Siemens Healthineers buys Fast Track Diagnostics for precision medicine tech
Healthcare IT News
Adding Fast Track Diagnostics molecular-testing technologies enables hospitals to target conditions such as respiratory infections, gastroenteritis, meningitis, hepatitis, infections of the immunosuppressed, tropical diseases, sexually transmitted ...

and more »


Newsweek

History of Medicine: Ancient Poop Reveals Parasitic Worms Described by Hippocrates 2500 Years Ago
Newsweek
Researchers studying prehistoric poop on the Greek island of Kea have finally identified the parasitic worms that Hippocrates, the ancient Greek physician widely considered the father of modern medicine, described in his famous medical texts 2,500 ...

and more »


Mirror.co.uk

Why you should never take cough medicine when you're ill
Mirror.co.uk
Coughs and colds are rampant in the UK at the moment after a sudden turn in the weather. People probably regretted playing in all that snow as soon as they started sneezing. And in the run-up to Christmas, desperate to be well for the festive season ...



Personalized Medicine Faces 4 Key Challenges in the US Marketplace
AJMC.com Managed Markets Network
The landscape for the regulation of personalized medicine is still in its infancy. Despite the FDA's strides in producing draft guidance and other documents that concern a regulatory pathway for personalized medicine diagnostics (such as the 2017 ...



Washington University School of Medicine in St. Louis

Study prompts new ideas on cancers' origins
Washington University School of Medicine in St. Louis
“As scientists, we have focused a good deal of attention on understanding the role of stem cells in the development of cancers, but there hasn't been a focus on mature cells,” said senior investigator Jason C. Mills, MD, PhD, a professor of medicine in ...

and more »


Science Trends

The Missing Link For Effective Regenerative Medicine: A Novel Source Of Highly Differentiable Stem Cells
Science Trends
Finding a reliable source of cells with wide differentiation capacity in adult organisms would provide a promising tool for regenerative medicine, specifically in facilitating autologous treatment. Mesenchymal stem cells (MSCs) are classified as ...

and more »


KXLH Helena News

Medicine Springs Mineral Therapy makes Top 10 list
KXLH Helena News
Medicine Springs Mineral Therapy, a Montana business featured last year in our weekly Montana Made segment, has been named one of the best products of 2017 by a national publication. Vitamin Retailer Magazine named Medicine Springs Mineral Therapy to ...

and more »

Google News

home | site map | Dr. Thad Thomas
© 2006